Press releases and news of the Cluster of Excellence

Seven members of the Cluster of Excellence “Precision Medicine in Chronic Inflammation” are also among the world’s most frequently cited researchers…

Researchers from Borstel, Lübeck, and Kiel identify two key messengers that trigger persistent inflammation in the nasal mucosa.

New microbiome platform at Kiel University enables interdisciplinary and more comprehensive microbiome analyses

Research team in Kiel identifies two genetic alterations that, when combined, may increase the risk of colorectal cancer in people with chronic…

Two days full of exchange, new ideas, and joint planning: The cluster meeting prepared members for the upcoming funding period and provided space for…

The Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI) mourns the loss of its member of the scientific advisory board Prof. Dr.…

Researchers at the FZB have defined the areas in which the development of resistance to two important tuberculosis drugs is favored.

A specific intestinal bacterium produces sphingolipids, via an alternative metabolic pathway, that provide host protection against infection. 
 

The new Research Training Group GRK3095 will investigate the mechanisms by which antibodies trigger either protective or disease-causing responses in…

Immunologist from the Cluster of Excellence PMI receives prestigious European Research Council grant for work on regulatory T cells.